Phillips-Medisize, a Molex company and leader in the design, development, and manufacturing of drug delivery, diagnostic, and MedTech devices, is collaborating with Subcuject, an innovator of proprietary device platforms, to bring a wearable bolus injector to market.    The On-Body Delivery System technology, based on osmosis, is now available for the next stage of drug-specific wearable injector solution development following Subcuject’s intellectual property filing of the concept.    “We...